The relationship between life-sustaining treatment limitation and organ donation in Swedish intensive care: A nationwide register study.

brain death end-of-life life-sustaining treatment organ donation resuscitation orders

Journal

Acta anaesthesiologica Scandinavica
ISSN: 1399-6576
Titre abrégé: Acta Anaesthesiol Scand
Pays: England
ID NLM: 0370270

Informations de publication

Date de publication:
Sep 2021
Historique:
revised: 05 04 2021
received: 27 08 2020
accepted: 07 04 2021
pubmed: 19 4 2021
medline: 16 10 2021
entrez: 18 4 2021
Statut: ppublish

Résumé

Life-sustaining treatment limitation (LSTL) on the intensive care unit (ICU) may affect the rate of organ donation after brain death (DBD). The primary aim of this study was to examine whether there is a relationship between LSTL and DBD. Furthermore, we aimed to determine the rate of LSTL involved in ICU deaths and to describe technical and procedural characteristics of LSTL on Swedish ICUs. This was an observational cohort study on all ICU deaths (n = 13 156) in Sweden between 2014 and 2017. We analysed differences in DBD rates between deaths in ICU with and those without LSTL, using descriptive statistics and logistic regression. After excluding 1084 deaths on specialised ICUs and units not registering goals of treatment, the study population comprised 12 072 deaths including 615 DBDs, of which 7865 had LSTL, 1706 had no LSTL and 2501 had no stated goals of treatment. The final cohort on which the relationship between DBD and LSTL was analysed comprised 9571 deaths including 419 DBDs. When no LSTL was documented, the rate of organ donation was 9.5% compared to 3.3% when LSTL was documented (P < .001). LSTL was associated with a lower DBD rate after adjusting for patient- and ICU-related factors (OR 0.41, 95% CI 0.31-0.53, P < .001). There was an inverse relationship between LSTL and DBD amongst patients who died on the ICU. This relationship remained after adjusting for factors known to influence organ donation. The reason remains to be determined.

Sections du résumé

BACKGROUND BACKGROUND
Life-sustaining treatment limitation (LSTL) on the intensive care unit (ICU) may affect the rate of organ donation after brain death (DBD). The primary aim of this study was to examine whether there is a relationship between LSTL and DBD. Furthermore, we aimed to determine the rate of LSTL involved in ICU deaths and to describe technical and procedural characteristics of LSTL on Swedish ICUs.
METHODS METHODS
This was an observational cohort study on all ICU deaths (n = 13 156) in Sweden between 2014 and 2017. We analysed differences in DBD rates between deaths in ICU with and those without LSTL, using descriptive statistics and logistic regression.
RESULTS RESULTS
After excluding 1084 deaths on specialised ICUs and units not registering goals of treatment, the study population comprised 12 072 deaths including 615 DBDs, of which 7865 had LSTL, 1706 had no LSTL and 2501 had no stated goals of treatment. The final cohort on which the relationship between DBD and LSTL was analysed comprised 9571 deaths including 419 DBDs. When no LSTL was documented, the rate of organ donation was 9.5% compared to 3.3% when LSTL was documented (P < .001). LSTL was associated with a lower DBD rate after adjusting for patient- and ICU-related factors (OR 0.41, 95% CI 0.31-0.53, P < .001).
CONCLUSION CONCLUSIONS
There was an inverse relationship between LSTL and DBD amongst patients who died on the ICU. This relationship remained after adjusting for factors known to influence organ donation. The reason remains to be determined.

Identifiants

pubmed: 33866543
doi: 10.1111/aas.13832
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1095-1101

Informations de copyright

© 2021 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Références

Bendorf A, Kerridge IH, Stewart C. Intimacy or utility? Organ donation and the choice between palliation and ventilation. Crit Care. 2013;17:316. https://doi.org/10.1186/cc12553
Parker M, Shemie S. Pro/con ethics debate: should mechanical ventilation be continued to allow for progression to brain death so that organs can be donated? Crit Care. 2002;6(5):399-402. https://doi.org/10.1186/cc1542
Citerio G, Cypel M, Dobb GJ, et al. Organ donation in adults: a critical care perspective. Intensive Care Med. 2016;42(3):305-315. https://doi.org/10.1007/s00134-015-4191-5
Citerio G, Crippa IA, Bronco A, et al. Variability in brain death determination in Europe: looking for a solution. Neurocrit Care. 2014;21(3):376-382. https://doi.org/10.1007/s12028-014-9983-x
Report of the Madrid Consultation: part 1: European and universal challenges in organ donation and transplantation, searching for global solutions. Transplantation. 2011;91(Suppl11):S39-S66. https://doi.org/10.1097/01.tp.0000399133.59371.98
merorgandonation MOD [Internet] available at https://merorgandonation.se/statistik-och-rapporter. Assessed 30 Dec 2020.
TNS Opinion & Social. Organ donation and transplantation. Special Eurobarometer 333a. [Internet]. 2010. http://ec.europa.eu/public_opinion/archives/ebs/ebs_333a_en.pdf. Assessed December 30, 2020
Krekula LG. Shining a light on organ donation after death [Internet]. 2015. https://openarchive.ki.se/xmlui/handle/10616/44707. Assessed December 30, 2020
Shaw D, Lewis P, Jansen N, et al. Family overrule of registered refusal to donate organs. J Intensive Care Soc. 2020;21(2):179-182. https://doi.org/10.1177/1751143719846416
Da Silva IRF, Frontera JA. Worldwide barriers to organ donation. JAMA Neurol. 2015;72(1):112-118. https://doi.org/10.1001/jamaneurol.2014.3083
Milton A. Organdonation: en livsviktig verksamhet. Fritzes. 2015. https://www.regeringen.se/contentassets/f3f266afc8b941fea785ee3d1a727a26/utredning-om-donations--och-transplantationsfragor-sou-201584. English summary at page 35-44. Accessed December 30, 2020
Heckscher S. Organbevarande behandling för donation [Internet]. 2019. https://www.riksdagen.se/sv/dokument-lagar/dokument/statens-offentliga-utredningar/sou-2019-26-_H7B326. English summary at page 23-29. Accessed December 30, 2020.
Kentish-Barnes N, Siminoff LA, Walker W, et al. A narrative review of family members’ experience of organ donation request after brain death in the critical care setting. Intensive Care Med. 2019;45(3):331-342. https://doi.org/10.1007/s00134-019-05575-4
Emilsson L, Lindahl B, Köster M, et al. Review of 103 swedish healthcare quality registries. J Intern Med. 2015;277(1):94-136. https://doi.org/10.1111/joim.12303
Metnitz PGH, Moreno RP, Almeida E, et al. SAPS 3-From evaluation of the patient to evaluation of the intensive care unit. Part 1: objectives, methods and cohort description. Intensive Care Med. 2005;31(10):1336-1344. https://doi.org/10.1007/s00134-005-2762-6
A’roch R, Berggren L, Edberg K-E, et al. Treatment strategies for Life Support in Intensive Care. The Swedish Society for Anaesthesia and Intensive Care (SFAI) 2012. [Internet]. https://sfai.se/wp-content/uploads/files/22-2%20Treatment_strategy.pdf. Accessed December 30, 2020
Nolin T, Mårdh C, Karlström G, Walther SM. Identifying opportunities to increase organ donation after brain death. An observational study in Sweden 2009-2014. Acta Anaesthesiol Scand. 2017;61(1):73-82. https://doi.org/10.1111/aas.12831
Moreno RP, Metnitz PGH, Almeida E, et al. SAPS 3 - From evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005;31(10):1345-1355. https://doi.org/10.1007/s00134-005-2763-5
Domínguez-Gil B, Murphy P, Procaccio F. Ten changes that could improve organ donation in the intensive care unit. Intensive Care Med. 2016;42(2):264-267. https://doi.org/10.1007/s00134-015-3833-y
Lesieur O, Mamzer M-F, Leloup M, et al. Eligibility of patients withheld or withdrawn from life-sustaining treatment to organ donation after circulatory arrest death: epidemiological feasibility study in a French Intensive Care Unit. Ann Intensive Care. 2013;3(1):36. https://doi.org/10.1186/2110-5820-3-36
Cook G. The sound of silence: rationing resources for critically ill patients. Crit Care. 1999;3(1):R1-R3. https://doi.org/10.1186/cc309
Scheunemann LP, White DB. The ethics and reality of rationing in medicine. Chest. 2011;140(6):1625-1632. https://doi.org/10.1378/chest.11-0622
Luce JM, White DB. The pressure to withhold or withdraw life-sustaining therapy from critically ill patients in the United States. Am J Respir Crit Care Med. 2007;175(11):1104-1108. https://doi.org/10.1164/rccm.200609-1397CP
Rhodes A, Ferdinande P, Flaatten H, et al. The variability of critical care bed numbers in Europe. Intensive Care Med. 2012;38(10):1647-1653. https://doi.org/10.1007/s00134-012-2627-8
Strand K, Walther SM, Reinikainen M, et al. Variations in the length of stay of intensive care unit nonsurvivors in three scandinavian countries. Crit Care. 2010;14(5):R175. https://doi.org/10.1186/cc9279
Spronk PE, Kuiper AV, Rommes JH, et al. The practice of and documentation on withholding and withdrawing life support: a retrospective study in two Dutch intensive care units. Anesth Analg. 2009;109(3):841-846. https://doi.org/10.1213/ane.0b013e3181acc64a
Hoel H, Skjaker SA, Haagensen R, Stavem K. Decisions to withhold or withdraw life-sustaining treatment in a Norwegian intensive care unit. Acta Anaesthesiol Scand. 2014;58(3):329-336. https://doi.org/10.1111/aas.12246
Ferrand E, Robert R, Ingrand P, Lemaire F; French LATAREA Group. Withholding and withdrawal of life support in intensive-care units in France: a prospective survey. French LATAREA Group. Lancet. 2001;357(9249):9-14. https://doi.org/10.1016/s0140-6736(00)03564-9
Long AC, Brumback LC, Curtis JR, et al. Agreement with consensus statements on end-of-life care: a description of variability at the level of the provider, hospital, and country. Crit Care Med. 2019;47(10):1396-1401. https://doi.org/10.1097/CCM.0000000000003922
Mark NM, Rayner SG, Lee NJ, Curtis JR. Global variability in withholding and withdrawal of life-sustaining treatment in the intensive care unit: a systematic review. Intensive Care Med. 2015;41(9):1572-1585. https://doi.org/10.1007/s00134-015-3810-5
Report of the Madrid Consultation: part 1: European and universal challenges in organ donation and transplantation, searching for global solutions. Transplantation. 2011;91(Suppl 11):S39-66. https://doi.org/10.1097/01.tp.0000399133.59371.98

Auteurs

Thomas Nolin (T)

Department of Anaesthesiology, Central Hospital, Kristianstad, Sweden.
The Swedish Intensive Care Registry, Karlstad, Sweden.

Sten Walther (S)

Department of Cardiovascular Anaesthesia and Intensive Care, Heart Centre and Department of Medical and Health Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH